In 2015 alone, it is estimated that approximately 8500 Canadians will be diagnosed with the most aggressive form of skin cancer: melanoma. Often forming from an abnormal mole or lesion on the skin, early detection of melanoma can be life-saving. That is why Mitacs Globalink research intern Suranjana Samanta has dedicated her studies to furthering technologies that can save lives through the accurate and early detection of cancers.
"This experience has taught me that when you are here in Canada, you really can do anything you put your mind to,” says Sarahi Anguiano Gutierrez, a mechanical engineering student from Tecnológico de Monterrey, Mexico.
Laura Solis Rodriguez is about to enter her final year at Mexico’s Instituto Tecnológico y de Estudios Superiores de Monterrey, where she’s a marketing and communications student. Because of her specialization in advertising photography, Laura was used to thinking about objects in terms of how to market them to potential customers. She didn’t expect to apply her photography skills to archeological artifacts!
Luz Anchondo Vásquez has always had an interest in helping people. She’s combining that interest with her mechatronics background, thanks to the Globalink Research Internship.
Luz first heard about the Globalink Research Internship through her university, Mexico’s Tecnológico de Monterrey Campus Chihuahua. With the support of a friend who was a previous intern, Luz applied and was matched on a project with Dr. Lionel Birglen at École Polytechnique de Montréal’s Mechanical Engineering department.
He had applied the previous year and undertook a research project in Montreal.
Equipped with first-hand information from her friend, Laura submitted her application. She was matched on a project supervised by Dr. Mike Van der Loos, in the University of British Columbia’s (UBC) Mechanical Engineering department. Laura is working in the CARIS lab, which is undertaking experimental research to advance the science of human-robot interaction.
During the summer of 2014, researchers at the University of Waterloo’s School of Pharmacy were looking into whether a group of drugs called selective serotonin re-uptake inhibitors (SSRIs) — normally used as anti-depressants — could be used to treat Alzheimer's.
When Actavis Specialty Pharmaceuticals Co. developed a new drug to treat uterine fibroids — benign tumors in a woman’s uterus — it partnered with Accelerate intern Bernice Tsoi to help create an economic model of the product. As a Health Research Methodology PhD student at McMaster University, conducting a thorough analysis of the drug’s costs and benefits was right up Bernice’s alley.
He’s already got a head start on this goal through his work this summer with Professor Vincent Jacquemet at the Hôpital du Sacré-Cœur—part of the Université de Montréal—through Mitacs Globalink Research Internships.
Mitacs thanks the Government of Canada and the Government of Quebec for their support of the Accelerate research internship in this story. Across Canada, the Accelerate program also receives support from Alberta Innovates, the Government of British Columbia, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, the Government of Prince Edward Island, the Government of Saskatchewan, and Research Manitoba.